Chemical activators of LRRIQ1 have various mechanisms through which they can enhance the protein's activity. Phorbol 12-myristate 13-acetate, commonly known as PMA, is known for its role in activating protein kinase C (PKC). PKC is a family of enzymes that are pivotal in several signal transduction cascades. Through phosphorylation, PKC directly targets LRRIQ1, leading to an increase in its activity. Another activator, Forskolin, works by elevating cyclic AMP (cAMP) levels within the cell, which in turn activates protein kinase A (PKA). PKA is then able to phosphorylate LRRIQ1, which results in the protein's functional enhancement. Similarly, the calcium ionophore Ionomycin raises intracellular calcium levels, which activates calcium/calmodulin-dependent protein kinase (CaMK). CaMK is then capable of phosphorylating LRRIQ1, thereby activating it. Thapsigargin and A23187 (Calcimycin) both act to increase intracellular calcium levels, albeit through different mechanisms, and this rise in calcium concentration leads to the activation of calcium-dependent kinases that can phosphorylate and activate LRRIQ1.
In addition, Okadaic Acid and Calyculin A are potent inhibitors of protein phosphatases PP1 and PP2A. The inhibition of these phosphatases prevents the dephosphorylation of many proteins, including LRRIQ1, which results in its sustained activation. Piceatannol, by inhibiting Syk kinase, can influence the kinase networks within the cell, which may lead to the activation of LRRIQ1 through altered phosphorylation patterns. Sphingosine 1-phosphate (S1P) activates G-protein-coupled receptors that stimulate downstream kinases such as PKA, which then phosphorylates and activates LRRIQ1. Epigallocatechin Gallate (EGCG) and IBMX both work to maintain higher levels of cAMP by inhibiting phosphodiesterases, thus promoting PKA activity and subsequent phosphorylation and activation of LRRIQ1. Lastly, Anisomycin activates stress-activated protein kinases (SAPKs), which can phosphorylate and activate LRRIQ1 as a part of the cellular response to stress. Each of these chemicals, through their unique actions on specific kinases or signaling molecules, are able to promote the activation of LRRIQ1, thus amplifying its function within the cellular context.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which is known to phosphorylate a variety of proteins. PKC-mediated phosphorylation of LRRIQ1 activates its function. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium concentrations, activating calcium/calmodulin-dependent protein kinase (CaMK). CaMK can phosphorylate and activate LRRIQ1. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the SERCA pump, raising intracellular calcium levels, which activates calcium-dependent kinases that can then activate LRRIQ1 by phosphorylation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, raising calcium levels inside cells, which activates calcium-dependent kinases that phosphorylate and activate LRRIQ1. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases PP1 and PP2A, preventing dephosphorylation of proteins, which can result in the activation of LRRIQ1 through sustained phosphorylation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, similar to Okadaic Acid, inhibits protein phosphatases leading to increased phosphorylation. This inhibition can result in the activation of LRRIQ1 through enhanced phosphorylation. | ||||||
Piceatannol | 10083-24-6 | sc-200610 sc-200610A sc-200610B | 1 mg 5 mg 25 mg | $51.00 $71.00 $199.00 | 11 | |
Piceatannol inhibits Syk kinase which might lead to altered phosphorylation patterns and cross-talk in kinase networks, which can activate LRRIQ1. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P can activate G-protein-coupled receptors that subsequently activate downstream kinases such as PKA, which in turn can phosphorylate and activate LRRIQ1. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits phosphodiesterases, maintaining high levels of cAMP, thus enhancing PKA activity. PKA phosphorylates and activates LRRIQ1. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases non-specifically, maintaining cAMP levels, which enhances PKA activity and therefore the phosphorylation and activation of LRRIQ1. | ||||||